Our findings are also in line with the two-stage model of tumor-specific CD8+ T-cell activation wherein initial T-cell priming in tdLNs is followed by differentiation of tumor-infiltrating stem-like CD8+ T cells into effector cells within the tumor upon receiving additional co-stimulatory signals47. The gene discussed is CD8A; the disease is neoplasm.